Maureen Hillenmeyer

Hexagon Bio

Maureen Hillenmeyer is the Founder and CEO of Hexagon Bio, a biotech company using data science and synthetic biology to turn the world's DNA into new medicines. Previously, she was director of the Genomes to Natural Products program and group leader at the Stanford Technology Genome Center.
SynBioBeta is the leading community of entrepreneurs, investors, policymakers and enthusiasts devoted to the responsible growth of the synthetic biology field. We’re dedicated to telling the stories of the field and companies involved, building their networks, and helping them grow.
Get Social
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram